About Micrima
Micrima is a company based in Bristol (United Kingdom) founded in 2005 by Roy Johnson. It operates as a HealthTech. Micrima has raised $19.34 million across 9 funding rounds from investors including University of Bristol, Nesta and YFM Equity Partners. The company has 25 employees as of December 31, 2020. Micrima offers products and services including Mi~Scan® and Mi~Scan®+. Micrima operates in a competitive market with competitors including Vayyar, Niramai, CairnSurgical, UE LifeSciences and CMR Naviscan, among others.
- Headquarter Bristol, United Kingdom
- Employees 25 as on 31 Dec, 2020
- Founders Roy Johnson
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Micrima Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$19.34 M (USD)
in 9 rounds
-
Latest Funding Round
$13.97 K (USD), Series A
Apr 21, 2021
-
Investors
University of Bristol
& 8 more
-
Employee Count
25
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Micrima
Micrima offers a comprehensive portfolio of products and services, including Mi~Scan® and Mi~Scan®+.
Breast density is measured non-invasively without harmful radiation.
Personalized risk profile is provided for breast cancer.
People of Micrima
Unlock access to complete
Funding Insights of Micrima
Micrima has successfully raised a total of $19.34M across 9 strategic funding rounds. The most recent funding activity was a Series A round of $13.97 thousand completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Micrima
Micrima has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include University of Bristol, Nesta and YFM Equity Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early stage tech companies are introduced to suitable investors.
|
Locked | Locked | Locked | |
|
Venture capital is provided to innovative technology companies.
|
Locked | Locked | Locked | |
|
Tech startups receive investments from this London-based venture capital firm.
|
Locked | Locked | Locked |
Investor details for Micrima
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Micrima
Investment portfolio details for Micrima
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Micrima
Detailed financials for Micrima
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Micrima Comparisons
Peer comparison for Micrima
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Micrima
Micrima operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Vayyar, Niramai, CairnSurgical, UE LifeSciences and CMR Naviscan, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of 4D imaging sensors for cancer detection and other devices
|
|
| Locked | Locked | Locked |
Early breast cancer is detected using AI-based non-invasive thermal imaging.
|
|
| Locked | Locked | Locked |
Developer of 3D printed surgical guides for breast cancer treatment
|
|
| Locked | Locked | Locked |
Non-invasive devices for breast and cervical cancer screening are provided.
|
|
| Locked | Locked | Locked |
High-resolution PET scanners for breast imaging are developed and manufactured.
|
|
| Locked | Locked | Locked |
Intraoperative cancer detection devices are developed for real-time tissue assessment.
|
Detailed competitors of Micrima
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Micrima
Complete news archive for Micrima
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Micrima
Micrima was founded in 2005.
Micrima is headquartered in Bristol, United Kingdom. It is registered at Bristol, England, United Kingdom.
Micrima is a funded company, having raised a total of $19.34M across 9 funding rounds to date.
As of Dec 31, 2020, the latest employee count at Micrima is 25.
Micrima is engaged in developing non-invasive breast cancer risk assessment tools. Solutions like MiScan and MiScan are offered to measure breast density and provide personalized risk profiles. The healthcare sector is primarily targeted, with an emphasis on early detection support. Women of all ages are served without the need for referrals. Harmful radiation and compression are avoided in the scanning process. Statistical risk information is provided to empower health decisions.
Micrima's top competitors include CairnSurgical, Niramai and UE LifeSciences.
Micrima offers Mi~Scan® and Mi~Scan®+.
Micrima has 9 investors. Key investors include University of Bristol, Nesta, YFM Equity Partners, GWC, and Technology Venture Partners.
The valuation of Micrima is $13.87M as of Apr 2021.